Edesa Biotech Inc

NASDAQ:EDSA  
5.45
-0.25 (-4.39%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Edesa Biotech Inc Stock, NASDAQ:EDSA

100 Spy Court, Markham, Ontario L3R 5H6
Canada
Phone: +1.289.800.9600
Number of Employees: 12

Description

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing and commercializing clinical stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. The company product candidate, EB01 is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis (ACD), a common, potentially debilitating condition and occupational illness. EB01 employs a novel, non-steroidal mechanism of action and in two clinical studies has demonstrated statistically significant improvement of multiple symptoms in ACD patients. Edesa Biotech was founded on June 12, 2007 and is headquartered in Markham, Canada.